DOI QR코드

DOI QR Code

Establishment of Acceptable Daily Intakes (ADIs) and Risk Assessment for Ephedrine, Menichlopholan, Anacolin, and Etisazole Hydrochloride

  • Min Ji Kim (Pesticide and Veterinary Drug Residues Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Ji Young Kim (Pesticide and Veterinary Drug Residues Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Jang Duck Choi (Pesticide and Veterinary Drug Residues Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Guiim Moon (Pesticide and Veterinary Drug Residues Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
  • Received : 2022.10.04
  • Accepted : 2022.11.29
  • Published : 2022.12.31

Abstract

BACKGROUND: Prior to implementing a positive list system (PLS), there is a need to establish acceptable daily intake (ADI) and maximum residue limit (MRL) for veterinary drugs that have been approved a few decades ago in South Korea. On top of that, chronic dietary exposure assessment of veterinary drug residues should be performed to determine whether the use of these veterinary drugs would cause health concerns or not. METHODS AND RESULTS: To establish the ADI, the relevant toxicological data were collected from evaluation reports issued by international organizations. A slightly modified global estimate of chronic dietary exposure (GECDE) model was employed in the exposure assessment owing to the limited residual data. Therefore, only the ADI of ephedrine was established due to insufficient data for the other veterinary drugs. Thus, instead of ADI, the threshold of toxicological concern (TTC) value was used for the other drugs. Lastly, the hazard index (HI) was calculated, except for etizazole hydrochloride, due to the potential of mutagenicity. CONCLUSION(S): The HI values of ephedrine, menichlopholan, and anacolin were found to be as high as 6.4%, suggesting that chronic dietary exposure to the residues from these uses was unlikely to be a public health concern. Further research for exposure assessment of veterinary drug residues should be performed using up-todate Korean national health and nutrition examination survey (KNHANES) food consumption data. In addition, all relevant available data sources should be utilized for identifying the potentials of toxicity.

Keywords

Acknowledgement

This study was supported by a grant (No. 21161 MFDS361) from the Ministry of Food and Drug Safety of Korea for 2021.

References

  1. Falowo AB, Akimoladun OF (2019) Veterinary drug residues in meat and meat products: Occurrence, detection and implications. Veterinary Medicine and Pharmaceuticals, 3, 19. https://doi.org/10.5772/intechopen.79335.
  2. Korea Rural Economic Institute (2021) 2020 Food Balance Sheet. https://library.krei.re.kr/pyxis-api/1/digital-files/cdb85104-ca3e-40a4-970b-dd37a3d3c00a, [Accessed on 4 October 2022].
  3. OECD-FAO Agricultural Outlook (2022) OECD-FAO Agricultural Outlook 2022-2031. pp. 189-195, ISBN 978-92-5-136313-3, https://doi.org/10.1787/f1b0b29c-en.
  4. Munoz-Pineiro M, Robouch P (2018) Fipronil in eggs: Factsheet - December 2017, European Commission, JRC110632. https://publications.jrc.ec.europa.eu/repository/handle/JRC110632.
  5. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (2013) Scientific opinion on safety evaluation of Ephedra species for use in food. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). EFSA Journal, 11(11), 3467. https://doi.org/10.2903/j.efsa.2013.3467.
  6. Rim HJ (1975) Studies on the chemotherapy of trematode infections in Korea. Korean University Medical Journal, 12(2), 425-457.
  7. Lerche P (2015) Anticholinergics, in: Grimm KA, Lamont LA, Tranquilli WJ, Greene SA, Robertson SA, Veterinary Anesthesia and Analgesia. pp.178-182, John Wiley & Sons, Hoboken, NJ, USA. https://doi.org/10.1002/9781119421375.ch8.
  8. Cayir A, Coskun M, Coskun M (2016) Genotoxicity of commercial fungicide Cabrio Plus on human cell. Cytotechnology, 68(5), 1697-1704. https://doi.org/10.1007/s10616-015-9919-09.
  9. Zhang X, Zhang P, Perez-Rodriguez V, Souders II CL, Martyniuk CJ (2020) Assessing the toxicity of the benzamide fungicide zoxamide in zebrafish (Danio rerio): Towards an adverse outcome pathway for beta-tubulin inhibitors. Environmental Toxicology and Pharmacology, 78, 103405. https://doi.org/10.1016/j.etap.2020.103405.
  10. European Food Safety Authority and World Health Organization (2016) Review of the Threshold of Toxicological Concern (TTC) approach and development of new TTC decision tree. EFSA Supporting Publications, 13(3), 1006E. https://doi.org/10.2903/sp.efsa.2016.EN-1006.
  11. Axelrod J (1953) Studies on sympathomimetic amines. I. The biotransformation and physiological disposition of l-ephedrine and l-norephedrine. Journal of Pharmacology and Experimental Therapeutics, 109(1), 62-73.
  12. Sinsheimer JE, Dring LG, Williams RT (1973) Species differences in the metabolism of norephedrine in man, rabbit and rat. Biochemical Journal, 136(3), 763-771. https://doi.org/10.1042/bj1360763.
  13. Williams RT, Caldwell J, Dring LG (1973) Comparative metabolism of some amphetamines in various species. Frontiers in Catecholamine Research, 927-932. https://doi.org/10.1016/B978-0-08-017922-3.50176-3.
  14. Marvola M (1976) Effect of acetylated derivatives of some sympathomimetic amines onthe acute toxicity, locomotor activity and barbiturate anaesthesia time in mice. Acta Pharmacologica et Toxicologica, 38(5), 474-489. https://doi.org/10.1111/j.1600-0773.1976.tb03143.x.
  15. Graham BE, Kuizenga MH (1948) A pharmacologic study of ortho-methoxy-betaphenyl-Isopropyl methylamine hydrochloride, and 13 related methoxy analogues. Journal of Pharmacology and Experimental Therapeutics, 94(2), 150-166.
  16. Chen KK (1926) The effect of repeated administration of ephedrine. Journal of Pharmacology and Experimental Therapeutics, 27(1), 77-86.
  17. Warren MR, Werner HW (1946) Acute toxicity of vasopressor amines; Comparative data. Journal of Pharmacology and Experimental Therapeutics, 86(3), 284-286.
  18. Hilliard CA, Armstrong MJ, Bradt CI, Hill RB, Greenwood SK, Galloway SM (1998) Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environmental and Molecular Mutagenesis, 31(4), 316-326. https://doi.org/10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.0.CO;2-G.
  19. McGregor DB, Riach CG, Brown A, Edwards I, Reynolds D, West K, Willington S (1988) Reactivity of catecholamines and related substances in the mouse lymphoma L5178Y cell assay for mutagens. Environmental and Molecular Mutagenesis, 11(4), 523-544. https://doi.org/10.1002/em.2850110413.
  20. Radakovi M, Djeli N, Stanimirovi Z, Plecas-Solarovic B, Spremo-Potarevic B, Zivkovic L, Bajic V (2011) Evaluation of the effects of ephedrine on human lymphocytes in the comet assay. Acta Veterinaria, 61, 363-371. https://doi.org/10.2298/AVB1104363R.
  21. Storer RD, McKelvey TW, Kraynak AR, Elia MC, Barnum JE, Harmon LS, Nichols WW, DeLuca JG (1996) Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds. Mutation Research/Genetic Toxicology, 368(2), 59-101. https://doi.org/10.1016/0165-1218(95)00070-4.
  22. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K (1988) Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environmental and Molecular Mutagenesis, 11(S12), 1-157.
  23. Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B, Peyron I, Diquet B, Lechat P (2001) Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. European Journal of Clinical Pharmacology, 57(6), 447-455. https://doi.org/10.1007/s002280100317.
  24. Liles JT, Dabisch PA, Hude KE, Pradhan L, Varner KJ, Porter JR, Hicks AR, Corll C, Baber SR, Kadowitz PJ (2006) Pressor responses to ephedrine are mediated by a direct mechanism in the rat. Journal of Pharmacology and Experimental Therapeutics, 316(1), 95-105. https://doi.org/10.1124/jpet.105.090035.
  25. Marvola M and Kivirinta R (1978) Pharmacokinetics and locomotor activity increasing effect of ephedrine in mice. Acta Pharmacologica et Toxicologica, 43(5), 381-386. https://doi.org/10.1111/j.1600-0773.1978.tb02282.x.
  26. World Health Organization & Food and Agriculture Organization of the United Nations (2008) Principles and methods for the risk assessment of chemicals in food. Environmental Health Criteria 240 Chapter 5: Dose-response assessment and derivation of health-based guidance values. https://www.who.int/publications/i/item/9789241572408, [Accessed on 31 December 2008].
  27. Stockley CS, Wing LM, Tonkin AL, Miners JO (1994) Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine. Clinical Pharmacology and Therapeutics, 55(1), 35-43. https://doi.org/10.1038/clpt.1994.7.
  28. Sever PS, Dring LG, Williams RT (1975) The metabolism of (-)-ephedrine in man. European Journal of Clinical Pharmacology, 9(2), 193-198. https://doi.org/10.1007/BF00614017.
  29. Rahman MM, Kabir A, Ahmed S, Islam MK, Rahman MS, Alam A, Mubeen MAA, Yasmin MS, Hossain MS et al. (2017) Nitroxynil uncouples oxidative phosphorylation in the cell mitochondria and a drug wherever injectables are preferred over drenches. Bangladesh Journal of Veterinary Medicine, 15(1), 45-49. https://doi.org/10.3329/bjvm.v15i1.34054.
  30. Vanhee J, Ceuterick A, Dooms M, Dooms-Goossens A (1980) Etisazole: An animal antifungal agent with skin sensitizing properties in man. Contact Dermatitis, 6(6), 443. https://doi.org/10.1111/j.1600-0536.1980.tb04994.x.
  31. Malten KE (1978) Therapeutics for pets as neglected causes of contact dermatitis in housewives. Contact Dermatitis, 4(5), 296-299. https://doi.org/10.1111/j.1600-0536.1978.tb04564.x.